Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00775957 · ClinicalTrials.gov registry record
Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma
A clinical trial, sponsored by University of Oklahoma.
- Terminated
- Registry status
- 35
- Enrollment target
NCT00775957: Clinical Trial study, sponsored by University of Oklahoma.
NCT00775957 is a clinical trial that was terminated before completion, run by University of Oklahoma. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00775957 was terminated before completion, sponsored by University of Oklahoma.
- TERMINATED
- Registry status
- 35 participants
- Enrollment target
Study Summary
A study to determine the accuracy of FLT-PET in quantifying tumor cell proliferation at the initial staging of patients with Non-Hodgkin's Lymphoma in comparison wit the "gold standard" FDG-PET.
Interventions
- PROCEDURE FLT-PET scan
- PROCEDURE FDG-PET scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2008-10 |
Why NCT00775957 stopped before completion
NCT00775957 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which FLT-PET scan is the first listed.
NCT00775957 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00775957 about?
NCT00775957 is a clinical study titled "Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma". A study to determine the accuracy of FLT-PET in quantifying tumor cell proliferation at the initial staging of patients with Non-Hodgkin's Lymphoma in comparison wit the "gold standard" FDG-PET.
What is the current status of trial NCT00775957?
This trial is currently terminated. The enrollment target is 35 participants. The study started on 2008-10.
What interventions are being tested in trial NCT00775957?
The interventions under investigation include: FLT-PET scan (PROCEDURE), FDG-PET scan (PROCEDURE).
Who is sponsoring clinical trial NCT00775957?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia